The most up to date reporting and breakthroughs in anal cancer and HPV research, and Anal Cancer Foundation’s latest activities and events.
The groundbreaking ANCHOR study showed that early detection and treatment of anal HSIL (anal precancer) reduces cancer progression by 57%. Today, the study and results were published in the New England Journal of Medicine. The study was conceived by Anal Cancer Foundation scientific advisory board member Dr. Joel Palefsky, and supported through advocacy efforts by the… read more
We recently held the inaugural webinars in our 2022 Expert Hour webinar series: Clinical Trials 101 and Immunotherapy 101. Dr. Lee Rosen of the University of California, Los Angeles, and Dr. Julius Strauss of the National Institutes of Health were the first two experts to hold informative and insightful sessions. We were thrilled at the… read more
We hope you will join us for a webinar for anal cancer thrivers and caregivers focused on immunotherapy! Date: Thursday, April 21 Time: 9am Pacific | 12pm Eastern Dr. Julius Strauss, medical oncologist and lead researcher at the National Cancer Institute, explains how immunotherapy works, who can benefit, key terms, and existing treatment and trials…. read more